Recursion outlines $375M 2026 cash OpEx guidance while advancing first Genentech neuroscience target
We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...
The aim of the programme is to offer a deep and up-to-date education in data science, machine learning and artificial intelligence that prepares graduates with key knowledge, skills and competencies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results